Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 2
1965 1
1966 1
1968 1
1969 3
1970 2
1971 5
1972 4
1973 8
1974 6
1975 1
1976 3
1977 7
1978 9
1979 4
1980 3
1981 1
1982 1
1983 3
1984 2
1985 3
1986 3
1987 7
1988 2
1989 2
1990 8
1991 7
1992 10
1993 8
1994 3
1995 4
1996 14
1997 9
1998 6
1999 8
2000 7
2001 7
2002 13
2003 6
2004 12
2005 5
2006 9
2007 6
2008 7
2009 7
2010 8
2011 10
2012 4
2013 10
2014 12
2015 2
2016 4
2017 8
2018 6
2019 8
2020 3
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Among authors: inbar m. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team. Piccart-Gebhart MJ, et al. Among authors: inbar m. N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306. N Engl J Med. 2005. PMID: 16236737 Free article. Clinical Trial.
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, Orlandi F, Mellars L, Alland L, Tendler C; CAELYX Breast Cancer Study Group. O'Brien ME, et al. Among authors: inbar m. Ann Oncol. 2004 Mar;15(3):440-9. doi: 10.1093/annonc/mdh097. Ann Oncol. 2004. PMID: 14998846 Free article. Clinical Trial.
Feature-Based Attention Samples Stimuli Rhythmically.
Re D, Inbar M, Richter CG, Landau AN. Re D, et al. Among authors: inbar m. Curr Biol. 2019 Feb 18;29(4):693-699.e4. doi: 10.1016/j.cub.2019.01.010. Epub 2019 Feb 7. Curr Biol. 2019. PMID: 30744973 Free article.
Nail-bed melanoma.
Klausner JM, Inbar M, Gutman M, Weiss G, Skornick Y, Chaichik S, Rozin RR. Klausner JM, et al. Among authors: inbar m. J Surg Oncol. 1987 Mar;34(3):208-10. doi: 10.1002/jso.2930340317. J Surg Oncol. 1987. PMID: 3821128
Carboplatin-related idiosyncrasy.
Inbar M, Merimsky O, Chaitchik S. Inbar M, et al. Anticancer Drugs. 1995 Dec;6(6):775-6. doi: 10.1097/00001813-199512000-00010. Anticancer Drugs. 1995. PMID: 8845491
Palliative treatment for advanced or metastatic osteosarcoma.
Merimsky O, Kollender Y, Inbar M, Meller I, Bickels J. Merimsky O, et al. Among authors: inbar m. Isr Med Assoc J. 2004 Jan;6(1):34-8. Isr Med Assoc J. 2004. PMID: 14740508 Free article. Review. No abstract available.
Cisplatin-related Lhermitte's sign.
Inbar M, Merimsky O, Wigler N, Chaitchik S. Inbar M, et al. Anticancer Drugs. 1992 Aug;3(4):375-7. doi: 10.1097/00001813-199208000-00010. Anticancer Drugs. 1992. PMID: 1421433
Plant coloration undermines herbivorous insect camouflage.
Lev-Yadun S, Dafni A, Flaishman MA, Inbar M, Izhaki I, Katzir G, Ne'eman G. Lev-Yadun S, et al. Among authors: inbar m. Bioessays. 2004 Oct;26(10):1126-30. doi: 10.1002/bies.20112. Bioessays. 2004. PMID: 15382135 Review.
310 results